Defining the role of radiofrequency ablation and stereotactic ablative radiotherapy in patients with high-risk, early-stage non-small cell lung cancer

Cancer. 2016 Jan 15;122(2):322-3. doi: 10.1002/cncr.29698. Epub 2015 Sep 30.

Authors

Alexander V Louie^{1

2}, Shankar Siva³, Suresh Senan²

Affiliations

¹ Department of Radiation Oncology, London Regional Cancer Program, London, Ontario, Canada.
² Department of Radiation Oncology, VU University Medical Center, Amsterdam, the Netherlands.
³ Department of Radiation Oncology, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia.

PMID: 26421800
DOI: 10.1002/cncr.29698

No abstract available

Publication types

Letter
Comment

MeSH terms

Carcinoma, Non-Small-Cell Lung / radiotherapy*
Catheter Ablation / methods*
Humans
Lung Neoplasms / radiotherapy*
Radiosurgery / methods*